(A) Design of gRNAs to the MpNOP1 locus to dissect efficiencies of induction of large deletions. Grey boxes and lines indicate exons and introns. The dotted line indicates the downstream region of MpNOP1. gRNA positions are shown in red lines. Primer sets for PCR-based genotyping are also shown. (B) Representative images of electrophoresis of PCR-based genotyping. The gRNAs and primer sets used in the genotyping are shown. Expected sizes of the PCR products from the wild-type genome are colored in blue. Expected sizes of the PCR products from the genome in which inductions of large deletion occurred are colored in magenta. PCR products from non-specific amplifications are indicated by asterisks. (C) Summary table of the co-transformation ex...
(A) Deletion and indel PCR screening. Representative clones exhibiting all possible band combination...
(A) Schematic illustration of pHM1B4-mediated simultaneous gene editing of xopN and xopV in PXO99A w...
Additional file 7. Validation of successful deletion of the IL1RAPL1 enhancer and the impact on alle...
<p><b>(a)</b> Three sets of PCR primers (<a href="http://www.plosone.org/article/info:doi/10.1371/jo...
(A) Classification of phenotypes in MpNOP1 genome editing lines by the appearance patterns of transp...
<p>(A) Structure of the pDECKO_mCherry vector. Note that the blue “target” regions contain protospac...
<p>(A) Schematic representation of the structure of partial <i>BmBlos2</i> gene as described in <a h...
(A) Gene model of the MpMPK1 gene and the gRNA target site. Grey boxes and lines indicate exons and ...
(a) Diagram depicting the plasmid vectors transfected into HEK293T cells containing pol II or pol II...
Additional file 6: Figure S3. Example showing simultaneous sgRNA efficiency in generating deletion i...
The newly-discovered Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-assoc...
(a) Diagram depicting the plasmid vectors transfected into HEK293T cells to induce targeted DSBs usi...
<p>(A) Schematic of the <i>EGFP</i> gene in a recombinant adenoviral genome with the target sites of...
<p>(<b>A</b>) Schematic representation of the zebrafish lncRNA <i>malat1</i> and the TALENs designed...
Additional file 7: Figure S4. PCR analyses of the T-DNA left border to determine completeness of int...
(A) Deletion and indel PCR screening. Representative clones exhibiting all possible band combination...
(A) Schematic illustration of pHM1B4-mediated simultaneous gene editing of xopN and xopV in PXO99A w...
Additional file 7. Validation of successful deletion of the IL1RAPL1 enhancer and the impact on alle...
<p><b>(a)</b> Three sets of PCR primers (<a href="http://www.plosone.org/article/info:doi/10.1371/jo...
(A) Classification of phenotypes in MpNOP1 genome editing lines by the appearance patterns of transp...
<p>(A) Structure of the pDECKO_mCherry vector. Note that the blue “target” regions contain protospac...
<p>(A) Schematic representation of the structure of partial <i>BmBlos2</i> gene as described in <a h...
(A) Gene model of the MpMPK1 gene and the gRNA target site. Grey boxes and lines indicate exons and ...
(a) Diagram depicting the plasmid vectors transfected into HEK293T cells containing pol II or pol II...
Additional file 6: Figure S3. Example showing simultaneous sgRNA efficiency in generating deletion i...
The newly-discovered Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-assoc...
(a) Diagram depicting the plasmid vectors transfected into HEK293T cells to induce targeted DSBs usi...
<p>(A) Schematic of the <i>EGFP</i> gene in a recombinant adenoviral genome with the target sites of...
<p>(<b>A</b>) Schematic representation of the zebrafish lncRNA <i>malat1</i> and the TALENs designed...
Additional file 7: Figure S4. PCR analyses of the T-DNA left border to determine completeness of int...
(A) Deletion and indel PCR screening. Representative clones exhibiting all possible band combination...
(A) Schematic illustration of pHM1B4-mediated simultaneous gene editing of xopN and xopV in PXO99A w...
Additional file 7. Validation of successful deletion of the IL1RAPL1 enhancer and the impact on alle...